Related Experiment Video
Updated: Jan 9, 2026

07:53
Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
Published on: October 13, 2023
2.0K
RPSLearner: A Novel Approach Based on Random Projection and Deep Stacking Learning for Categorizing Non-Small Cell
Xinchao Wu1, Jieqiong Wang2, Shibiao Wan1
1Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Advanced Intelligent Systems (Weinheim an Der Bergstrasse, Germany)
|December 5, 2025
Summary
RPSLearner accurately predicts non-small cell lung cancer (NSCLC) subtypes using random projection and ensemble learning. This novel approach improves upon existing methods for lung cancer diagnosis and classification.
Area of Science:
- Oncology
- Bioinformatics
- Machine Learning
Background:
- Non-small cell lung cancer (NSCLC) is the most common lung cancer subtype.
- Accurate diagnosis of NSCLC subtypes like adenocarcinoma and squamous cell carcinoma is challenging with conventional methods.
- Existing diagnostic techniques can be slow and inconclusive.
Purpose of the Study:
- To develop an accurate computational model for NSCLC subtype classification.
- To address the limitations of conventional diagnostic methods for lung cancer.
Main Methods:
- Proposed RPSLearner, combining random projection (RP) for dimensionality reduction and stacking ensemble learning.
- Utilized multiple independent RP matrices to reduce dimensionality of RNA-seq data.
- Employed a stack of diverse base classifiers with predictions integrated via a deep linear layer network.
Main Results:
- RPSLearner outperformed state-of-the-art approaches in lung cancer subtype classification on 1,333 NSCLC patients.
- Demonstrated efficient preservation of sample-to-sample distances post-dimension reduction.
- The meta-model and feature fusion method showed superior performance compared to individual base models and conventional score ensemble methods.
Conclusions:
- RPSLearner is a promising model for clinical diagnosis of lung cancer subtypes.
- The model's potential for extension to other cancer subtyping applications was highlighted.

